From: Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status
Chromogenic in situ hybridization
Immunohistochemistry
Total
Negative (0 and 1+)
Positive (2+ and 3+)
No amplification
80
22
102
With amplification
0
58
160